Effectiveness of glucocorticoid therapy in patients with severe coronavirus disease 2019: protocol of a randomized controlled trial

BACKGROUND: At the end of 2019, a novel coronavirus outbreak causative organism has been subsequently designated the 2019 novel coronavirus (2019-nCoV). The effectiveness of adjunctive glucocorticoid therapy in the management of 2019-nCoV-infected patients with severe lower respiratory tract infecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Yuan-Yuan, Zhou, Yi-Hong, Lu, Yan-Qiu, Sun, Feng, Yang, Sen, Harypursat, Vijay, Chen, Yao-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147272/
https://www.ncbi.nlm.nih.gov/pubmed/32149773
http://dx.doi.org/10.1097/CM9.0000000000000791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147272/
https://www.ncbi.nlm.nih.gov/pubmed/32149773
http://dx.doi.org/10.1097/CM9.0000000000000791

Ejemplares similares